- Home
- MLAB vs ARMN Comparison
MLAB vs ARMN Comparison
Compare MLAB & ARMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLAB
- ARMN
- Stock Information
- Founded
- MLAB 1982
- ARMN 1992
- Country
- MLAB United States
- ARMN Canada
- Employees
- MLAB N/A
- ARMN N/A
- Industry
- MLAB Industrial Machinery/Components
- ARMN
- Sector
- MLAB Industrials
- ARMN
- Exchange
- MLAB Nasdaq
- ARMN Nasdaq
- Market Cap
- MLAB 680.0M
- ARMN 769.7M
- IPO Year
- MLAB N/A
- ARMN N/A
- Fundamental
- Price
- MLAB $117.96
- ARMN $4.65
- Analyst Decision
- MLAB Hold
- ARMN
- Analyst Count
- MLAB 2
- ARMN 0
- Target Price
- MLAB $140.00
- ARMN N/A
- AVG Volume (30 Days)
- MLAB 48.0K
- ARMN 778.2K
- Earning Date
- MLAB 02-04-2025
- ARMN 03-12-2025
- Dividend Yield
- MLAB 0.54%
- ARMN N/A
- EPS Growth
- MLAB N/A
- ARMN 77.15
- EPS
- MLAB N/A
- ARMN 0.14
- Revenue
- MLAB $237,747,000.00
- ARMN $510,604,000.00
- Revenue This Year
- MLAB $13.48
- ARMN $49.45
- Revenue Next Year
- MLAB $4.74
- ARMN $4.63
- P/E Ratio
- MLAB N/A
- ARMN $31.85
- Revenue Growth
- MLAB 11.68
- ARMN 14.06
- 52 Week Low
- MLAB $83.68
- ARMN $3.29
- 52 Week High
- MLAB $155.12
- ARMN $5.16
- Technical
- Relative Strength Index (RSI)
- MLAB 37.05
- ARMN 58.12
- Support Level
- MLAB $121.89
- ARMN $4.34
- Resistance Level
- MLAB $130.12
- ARMN $4.88
- Average True Range (ATR)
- MLAB 4.45
- ARMN 0.20
- MACD
- MLAB -0.25
- ARMN 0.01
- Stochastic Oscillator
- MLAB 18.72
- ARMN 63.73
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
About ARMN Aris Mining Corporation
Aris Mining Corp is engaged in the acquisition, exploration, development and operation of gold properties in Colombia, Guyana and Canada. It owns and operates its Segovia Operations, Soto Norte Project and Marmato Mine in Colombia, Toroparu Project in Guyana and the Juby Project in Ontario, Canada. The company generates revenue from the sale of gold and silver.